ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI7676b33322324840ad2b154cc8e65b88. Once registered, a dial-in number, unique pin, and instructions will be provided to participants. The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following...

Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional Presentations at ASGCT Showcase Tenaya’s Work with Patients to Advance Gene Therapy and Early-Stage Pipeline Innovations in Cardiac Gene Editing SOUTH SAN FRANCISCO, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the acceptance of multiple abstracts for presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting, taking place May 11-15, 2026, in Boston, Massachusetts. Of note, new clinical data from both dose cohorts of the RIDGE-1...

Transaction Expected to Fill Capacity, Drive Near-Term Revenue Growth, and Increase Cash Flows; Demonstrate Management’s Commitment to Shareholders MIDLAND, Pa., April 27, 2026 (GLOBE NEWSWIRE) — Big Digital Energy, Inc. (“Big Digital” or the “Company”) (Nasdaq: MIGI; expected to change to “BGDE” on April 30, 2026), formerly known as Mawson Infrastructure Group Inc., today announced that it has entered into a strategic colocation agreement with an affiliate of the Endeavor Group (“Endeavor”). Endeavor consists of certain members of the Company’s management team. Under the terms of the agreement, Endeavor will purchase and deliver approximately 25,000 mining computers, and Big Digital will provide Endeavor with approximately 75MW of compute capacity. The Parties will operate under a 50%/50% profit-sharing arrangement whereby Big...

Company Showcases SteraMist iHP Automation to Industry Giants Including Amgen, Merck, and Moderna; Finalizes Custom Engineering Contract for Proprietary Healthcare System FREDERICK, Md., April 27, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, saw strong interest in its solutions at “INTERPHEX 2026” reflecting broader market awareness and acceptance of its products and positioning the Company to continue to build on the previously reported preliminary Q1 revenue and backlog. INTERPHEX 2026 is one of the premier trade shows in the pharmaceutical, biotechnology, and medical device industries held in New York City. INTERPHEX showcases innovative solutions and technologies that drive advancements in the life sciences sector. TOMI’s...

SOUTH BOSTON, Va., April 27, 2026 (GLOBE NEWSWIRE) — IperionX Limited (Nasdaq | ASX: IPX) is pleased to present its quarterly report for the period ended March 31, 2026. Highlights during and subsequent to the end of the quarter include: Operations – Titanium powder productionVirginia operations transitioned to a 24/7 production schedule during the quarter, marking the move from commissioning into continuous operations All HAMR™ powder production systems have been commissioned and are now in ramp-up, with IperionX targeting run-rate production of ~200 tpa of titanium powder by end-CY2026 HAMR™ powder production increased during the quarter, reaching ~4.2 metric tons in March, equivalent to approximately 50 tpa annualized. This represents the early-stage ramp rate, and throughput is expected to build as product mix...

Partnership Secures Advanced Well Technologies and Arctic Operating Expertise HOUSTON, April 27, 2026 (GLOBE NEWSWIRE) — via IBN — Greenland Energy Company (“Greenland”) (NASDAQ: GLND) today announced the signing of an agreement with Halliburton for integrated consulting services and logistical management relating to the planning, coordination, handling, and transportation of equipment, services, and goods. The agreement includes comprehensive well and drilling services for Greenland Energy’s onshore campaign in the Jameson Land Basin, a frontier region widely regarded as one of the most promising unexplored oil basins in the world. Building on Greenland Energy’s previously announced strategic agreements with Stampede Drilling and Desgagnés, the agreement with Halliburton forms a key component of the company’s integrated Arctic...

Conference call and live webcast today at 4:30 PM Eastern Time SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that the Company will host a conference call and webcast to discuss preliminary Phase 1 dose escalation data for its potentially best-in-class pan-RAS molecular glue ERAS-0015 in patients with RAS-mutant solid tumors today, Monday, April 27, 2026, at 4:30 pm ET. Conference Call and Webcast InformationErasca will hold a conference call and webcast Monday, April 27, 2026, at 4:30 pm ET. The webcast link for the conference call is here. The dial-in number is 1-877-407-3982 (U.S./Canada) or 1-201-493-6780 (international)...

Results Highlighted by Net Interest Margin Expansion and Tangible Net Book Value Growth to $30.55 Per Share WAUSAU, Wis., April 27, 2026 (GLOBE NEWSWIRE) — PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported earnings for the first quarter ending March 31, 2026 of $0.82 per diluted common share on net income of $3.3 million, compared to $0.97 per diluted common share on net income of $3.9 million during the fourth quarter ending December 31, 2025, and $0.60 per diluted common share on net income of $2.4 million during the first quarter ending March 31, 2025. PSB’s first quarter of 2026 operating results reflected the following changes from the fourth quarter of 2025: (1) a stronger net interest margin as loans and securities yields...

RICHMOND, Va., April 27, 2026 (GLOBE NEWSWIRE) — ARKO Petroleum Corp. (Nasdaq: APC) (“APC” or the “Company”), one of the largest wholesale fuel distributors by gallons in North America, today announced that the Company will host a conference call on Monday, May 11, 2026 at 9:00 a.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2026. APC’s management team will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call. Date: Monday, May 11, 2026Time: 9:00 a.m. Eastern TimeToll-free dial-in number: (877) 407-8306 International dial-in number: (201) 689-8481Webcast: APC’s Q1 2026 Earnings Call A telephonic replay will be available approximately three hours after the call concludes through Thursday,...

Program provides access to leronlimab for patients with limited treatment options while supporting ongoing clinical development VANCOUVER, Washington, April 27, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (“mTNBC”) and colorectal cancer (“mCRC”), today announced the successful enrollment and initial dosing of the first participant in its Expanded Access Program (EAP) for patients with triple-negative breast cancer (TNBC). The EAP is designed to provide eligible patients access to leronlimab outside of a clinical study setting. The program...